RACHEL SOBEK: Open Payments
NPI 1457956732 · VERO BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$801 in 36 payments from 11 companies in 2025. Trend: 2023 $24 · 2024 $808 · 2025 $801
Food & beverage: $801
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 4 | $208 |
| ABBVIE INC. | 11 | $168 |
| Regeneron Healthcare Solutions, Inc. | 4 | $107 |
| Novartis Pharmaceuticals Corporation | 5 | $92 |
| Amgen Inc. | 4 | $73 |
| Incyte Corporation | 2 | $43 |
| LEO Pharma Inc. | 1 | $28 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $28 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| PFIZER INC. | 1 | $16 |
Products named: DUPIXENT, SKYRIZI, OTEZLA, OPZELURA, ADBRY, ILUMYA, Sotyktu, LIBTAYO.
Industry payments across FL — which companies pay providers there.
